CONCORD MEDICAL - SPON ADR (CCM:NYSE)
$3.97 0.09 (2.3196%)
Analysed CONCORD MEDICAL - SPON ADR (CCM:NYSE) News Sources
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Friday Trading; Down 3% for Week
07-11-2025
yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
20-11-2025
yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
03-12-2025
yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading
12-01-2026
yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Slightly Higher in Tuesday Trading
13-01-2026
yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading
05-02-2026
yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
20-02-2026
yahoo.com
Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025
29-04-2026
yahoo.com
Asian Equities Traded in the US as American Depositary Receipts Edge Higher Friday
08-05-2026
yahoo.com
What is the current price of CONCORD MEDICAL - SPON ADR (CCM:NYSE)?
The current price of CONCORD MEDICAL - SPON ADR (CCM:NYSE) is $3.97.
CONCORD MEDICAL - SPON ADR (CCM:NYSE) absolute price change since previous trading day?
The absolute price change of CONCORD MEDICAL - SPON ADR (CCM:NYSE) since the previous trading day is $0.09.
CONCORD MEDICAL - SPON ADR (CCM:NYSE) percentage price change since previous trading day?
The percentage price change of CONCORD MEDICAL - SPON ADR (CCM:NYSE) since the previous trading day is 2.3196%.
What is the most recent average sentiment score for CONCORD MEDICAL - SPON ADR (CCM:NYSE)?
The most recent average sentiment score for CONCORD MEDICAL - SPON ADR (CCM:NYSE) is 33 out of 100.
What is the most recent average sentiment for CONCORD MEDICAL - SPON ADR (CCM:NYSE)?
The most recent sentiment for CONCORD MEDICAL - SPON ADR (CCM:NYSE) is .
SEC-8K** Filing Available For CONCORD MEDICAL - SPON ADR (CCM:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.